Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration.

Scientific reports - 10 Oct 2023

Lu Yiran, Guo Xinghong, Yang Mengmeng, Wang Kewei, Cao Guanglei, Liu Yan, Hou Xinguo, Chen Li, Liang Kai

Abstract excerpt

The preoperative diagnosis of thyroid nodules now routinely includes BRAFV600E genetic testing in most provincial and municipal hospitals in China. This study identified the most suitable patients of thyroid nodule for BRAFV600E genetic testing. We retrospectively collected data of patients from the Hospital Information System that had undergone fine needle aspiration biopsy (FNAB) from May 2019 to December 2021....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Open in PubMed Open full text

Identifiers

PMID: 37816788
DOI: 10.1038/s41598-023-44464-1
PMCID: PMC10564976

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration.PMID 37816788Read ↗

BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspirationSemantic proximity Read ↗

Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.Semantic proximity Read ↗

BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.Semantic proximity Read ↗

Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.Semantic proximity Read ↗

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read ↗

Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.Semantic proximity Read ↗

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.Semantic proximity Read ↗

Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodulesSemantic proximity Read ↗

Utilities of next-generation sequencing in the surgical management of thyroid nodules in China.Semantic proximity Read ↗

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.Semantic proximity Read ↗

Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.Semantic proximity Read ↗

BRAF V600E Mutation in Thyroid Carcinoma: A Large-Scale Study in Han Chinese PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.